Publication: Incidence and factors associated Post-transplantation anemia in kidney transplant patients at a tertiary-care hospital in Thailand
Issued Date
2020-07-01
Resource Type
ISSN
25868470
25868195
25868195
Other identifier(s)
2-s2.0-85088693708
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Pharmaceutical Sciences Asia. Vol.47, No.3 (2020), 294-300
Suggested Citation
Sayamon Sukkha, Panupong Tiansuwan, Kunvadee Choochaeam, Atiporn Ingsathit, Punlop Wiwattanathum, Jennis Meanwatthana Incidence and factors associated Post-transplantation anemia in kidney transplant patients at a tertiary-care hospital in Thailand. Pharmaceutical Sciences Asia. Vol.47, No.3 (2020), 294-300. doi:10.29090/psa.2020.03.019.0029 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/58085
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Incidence and factors associated Post-transplantation anemia in kidney transplant patients at a tertiary-care hospital in Thailand
Other Contributor(s)
Abstract
© 2020, Mahidol University - Faculty of Pharmacy. The scarce of standard recommendation for post-transplantation anemia (PTA) has resulted in different anemia approaches among transplant centers. The information of PTA in Thai kidney transplant patients is also lacking. We aimed to study the incidence of PTA during one year after transplantation. Factors associated PTA were investigated in Thai population. We performed a retrospective, cohort study from kidney transplant patients between 2014-2015. The primary objective was the incidence of PTA at one year after transplantation. Pre-defined factors were examined to predict the probability of PTA. Of 259 patients, the PTA incidence at one year after transplantation was 43.6%. Factors that increased risk of anemia included urinary tract infection, UTI (OR 2.170, 95% CI 1.434-3.248, P = 0.001), ganciclovir or valganciclovir (OR 1.522, 95% CI 0.926-2.501, P = 0.097), history of blood transfusion (OR 1.483, 95% CI 1.177-1.868, P = 0.001), history of using recombinant human erythropoietin, rHuEpo (OR 1.381, 95% CI 1.098-1.737, P = 0.006), duration of ESRD (OR 1.032, 95% CI 1.006-1.059, P = 0.015), and recipient's age (OR 1.019, 95% CI 1.009-1.030, P = 0.001). PTA was a common complication (43.6%) after transplantation in Thai kidney transplant patients. UTI, ganciclovir or valganciclovir, history of blood transfusion, history of using rHuEpo, duration of ESRD as well as recipient's age are associated with an increased risk of PTA. This information can assist practitioners to recognize the tendency of anemia and promising factors to proper management in our transplant center.